Work

A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer

Year: 2013

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdt121

Authors: S.M. Tolaney, J. Najita, J. Sperinde, W. Huang, W.Y. Chen, J. Savoie, M. Fornier, E.P. Winer, C. Bunnell, I.E. Krop

Institutions: Dana-Farber Cancer Institute, Brigham and Women's Hospital, Dana-Farber Brigham Cancer Center, Memorial Sloan Kettering Cancer Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

OpenAlex ID: W2168399952

FWCI: 0.357

Cites: 30

Cited by: 13

Related to: 10